The Effects of Virtual Reality-based Training for the Treatment of Neglect Syndrome in Stroke: a Randomized Controlled Trial
- Conditions
- Stroke ( 3 Months After Onset)Cognitive Dysfunction ( MMSE < 24 )Unilateral Neglect Syndrome
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 28
- Registration Number
- NCT07102927
- Locations
- 🇰🇷
Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- RemeGen Co., Ltd.
- Target Recruit Count
- 312
- Registration Number
- NCT07105215
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, China
🇨🇳The First Affiliated Hospital, Zhejiang University School Of Medicine, Hangzhou, China
🇨🇳Cancer Hospital of Shandong First Medical University, Jinan, China
Feasibility of Wireless Continuous Vital Sign Monitoring and Impact on Patients Undergoing Adult Spinal Surgery in a General Ward
- Conditions
- Adult Spinal DeformityWireless Continuous Vital Signs MonitoringWireless Vital Signs Monitoring SystemAcceptabilityASD SurgeryRemote MonitoringFeasibility Studies
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- Rigshospitalet, Denmark
- Target Recruit Count
- 150
- Registration Number
- NCT07105189
- Locations
- 🇩🇰
Department of Bone and Joint surgery, University hospital, Rigshospitalet, Copenhagen, Copenhagen, Denmark
Effect of Light Brightness on Well-being, Breastfeeding Motivation, and Psychological Well-being of Postpartum Mothers: A Randomized Placebo-controlled Trial
- Conditions
- Reduced Light Brightness
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- Emine Yıldırım
- Target Recruit Count
- 42
- Registration Number
- NCT07104071
A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment
- Conditions
- Bacterial Infections
- Interventions
- Drug: Cefiderocol/Xeruborbactam
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- Qpex Biopharma, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT07104162
- Locations
- 🇺🇸
University of Miami Clinical Pharmacology, Miami, Florida, United States
🇺🇸Orlando Clinical Research Center, Orlando, Florida, United States
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
- Conditions
- Epithelioid Hemangioendothelioma (EHE)
- Interventions
- Drug: nab-Sirolimus
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Target Recruit Count
- 41
- Registration Number
- NCT07104331
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸University of Colorado, Aurora, Colorado, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
Development and Testing of a Smoking Cessation Intervention Using Multi-Theory Model (MTM) Among Young Adults: A Randomized Controlled Trial
- Conditions
- Tobacco Use Disorder/Cigarette Smoking
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- University of Nevada, Las Vegas
- Target Recruit Count
- 144
- Registration Number
- NCT07104006
- Locations
- 🇺🇸
University of Nevada, Las Vegas, Las Vegas, Nevada, United States
Feasibility Trial of a Sub-conjunctival Insert
- Conditions
- Diabetes (DM)
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- EyeSense GmbH
- Target Recruit Count
- 8
- Registration Number
- NCT07105332
Comparing Short to Standard Amoxicillin Course for Erysipelas: a Non-inferiority Randomized Controlled Trial
- Conditions
- Erysipelas
- Interventions
- Drug: Course of amoxicillin
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 656
- Registration Number
- NCT07104552
The Effectiveness of a Mobile Game Intervention in Alcohol Use Disorder
- Conditions
- Alcohol Use Disorder
- Interventions
- Drug: Akamprosat or Naltrekson or combined medical treatment (Akamprosat and Naltrekson)Other: Mobile game app
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- University of Yalova
- Target Recruit Count
- 60
- Registration Number
- NCT07103785
- Locations
- 🇹🇷
Erenköy Ruh Ve Sinir Hastaliklari Eğitim Ve Araştirma Hastanesi, İstanbul, Turkey